Categories: Latest

Cadila Pharma honoured as the Best Company for Technology Innovation in Healthcare at ASSOCHAM Healthcare Summit

Ahmedabad , August 29, 2023:  Cadila Pharmaceuticals, one of the oldest and largest privately held drug manufacturers in the country, has been honoured as the “Best Company for Technology Innovation in Healthcare”at the prestigious 2nd Healthcare Summit and Awards organised by the Associated Chambers of Commerce and Industry of India (ASSOCHAM).

The award was bestowed upon Cadila Pharmaceuticals at a ceremony in New Delhi  recently by eminent Jury Members and Leaders of Healthcare Industry.

This prestigious Award reinforces Cadila Pharmaceuticals’ reputation among key opinion leaders and external stakeholders and enhancing its standing in the pharmaceuticals and healthcare industry.

Mr. Raj Prakash Vyas, President of Corporate Affairs at Cadila Pharmaceuticals, received the award on behalf of the company in the presence of who’s who from the healthcare ecosystem.

Speaking on the occasion, Mr Vyas reaffirmed Cadila Pharmaceuticals’ vision and mission of delivering innovative and affordable medicines and vaccines to the last man in society.

“With a succession of valuable innovations such as ThRabis, Rabeloc IV, Sepsivac, Polycap, Resorine, Cadiflu, MycidacC, and many others, Cadila Pharmaceuticals continues to bring forth affordable healthcare miracles, contributing to our national and  global healthcare ecosystem while upholding our commitment of “The Care Continues….”. This recognition reinforces our commitment to advancing healthcare technology and making a positive impact in people’s lives,” he said.

The eminent guests at the ASSOCHAM Healthcare Summit and Awards include Padma Shri Prof (Dr.) DS Rana, Chairperson and Board of Trustees Sir Ganga Ram Hospital, Dr. Vandana Talwar, Medical Superintendent of VMMC &Safdarjang Hospital, Ministry of Health & Family Welfare, Govt. of India, Prof (Dr.) RajinderDhamija, Director of Institute of Human Behaviour& Allied Sciences, Government of Delhi, Dr. Sudhir Kalhan, Chairman of Institute of Minimal Access, Metabolic & Bariatric Surgery at Sir Ganga Ram Hospital, Dr. Anil Agarwal, Director of G.B. Pant Institute of Postgraduate Medical Education & Research, Dr. Aashish Chaudhry, Senior Consultant & Head, Department of Orthopaedics& Joint Replacement & Managing Director, Aakash Healthcare, Shri OmprakashSubbarao, Programme Manager at National Health Authority, and others.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

20 hours ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

20 hours ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago